Your browser is no longer supported. Please, upgrade your browser.
Settings
ZGNX Zogenix, Inc. daily Stock Chart
ZGNX [NASD]
Zogenix, Inc.
Index- P/E- EPS (ttm)-3.56 Insider Own0.30% Shs Outstand26.39M Perf Week27.86%
Market Cap1.56B Forward P/E- EPS next Y-2.05 Insider Trans-45.11% Shs Float- Perf Month23.46%
Income-99.00M PEG- EPS next Q-0.89 Inst Own- Short Float- Perf Quarter44.92%
Sales7.10M P/S220.04 EPS this Y-18.90% Inst Trans0.13% Short Ratio6.92 Perf Half Y67.00%
Book/sh7.86 P/B7.53 EPS next Y46.40% ROA-45.90% Target Price64.20 Perf Year330.55%
Cash/sh10.31 P/C5.74 EPS next 5Y25.00% ROE-76.00% 52W Range10.05 - 62.75 Perf YTD47.82%
Dividend- P/FCF- EPS past 5Y6.90% ROI-29.40% 52W High-5.66% Beta2.09
Dividend %- Quick Ratio- Sales past 5Y-26.00% Gross Margin-15.70% 52W Low489.05% ATR2.74
Employees68 Current Ratio12.20 Sales Q/Q- Oper. Margin- RSI (14)76.32 Volatility6.58% 4.78%
OptionableYes Debt/Eq0.00 EPS Q/Q-1.70% Profit Margin- Rel Volume0.89 Prev Close61.10
ShortableYes LT Debt/Eq0.00 EarningsAug 08 AMC Payout- Avg Volume691.76K Price59.20
Recom1.50 SMA2023.35% SMA5033.97% SMA20046.74% Volume613,894 Change-3.11%
Jul-13-18Reiterated Stifel Buy $55 → $65
Nov-27-17Initiated JMP Securities Mkt Outperform
Oct-03-17Reiterated Mizuho Buy $28 → $51
Sep-29-17Upgrade William Blair Mkt Perform → Outperform
Oct-04-16Resumed Leerink Partners Outperform $17
Aug-11-15Reiterated Oppenheimer Outperform $20 → $23
Jul-15-15Reiterated Brean Capital Buy $20 → $28
Apr-22-15Initiated Piper Jaffray Overweight $2.50
Dec-29-14Initiated Brean Capital Buy $2.50
Jun-06-14Initiated R. F. Lafferty Buy $3.50
Oct-29-13Upgrade Stifel Hold → Buy $5
Jun-21-13Resumed Oppenheimer Perform
Mar-05-13Initiated Brinson Patrick Market Outperform
Dec-10-12Downgrade Stifel Nicolaus Buy → Hold
Dec-10-12Downgrade Oppenheimer Outperform → Perform $3
Jan-06-12Initiated William Blair Outperform
Sep-26-11Reiterated Oppenheimer Outperform $9 → $5
Jan-06-11Initiated Oppenheimer Outperform $9
Jan-03-11Initiated Stifel Nicolaus Buy $10
Jul-18-18 04:04PM  To make money on marijuana stocks, buy when the buzz is over MarketWatch
09:21AM  3 Big-Name Marijuana Stocks With Plunging Profit Projections Motley Fool
07:30AM  The Market That Took BEAT Higher By 800% Could Do The Same For This Strong New Competitor ACCESSWIRE
Jul-17-18 07:30AM  Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks ACCESSWIRE
Jul-16-18 08:49AM  Zogenix (ZGNX) in Focus: Stock Moves 9.8% Higher Zacks
08:00AM  Today's Research Reports on Trending Tickers: Zogenix and Momenta Pharmaceuticals ACCESSWIRE
Jul-14-18 02:02PM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Jul-13-18 05:34PM  Why Zogenix Inc. Shares Jumped 10% on Friday Motley Fool +9.75%
08:54AM  Zogenix's Epilepsy Candidate Successful in Phase III Study Zacks
08:34AM  Benzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering Benzinga
08:00AM  Today's Research Reports on Stocks to Watch: Galmed Pharmaceuticals and Zogenix ACCESSWIRE
Jul-12-18 05:15PM  Why Twitter, Papa John's International, and Zogenix Jumped Today Motley Fool +20.73%
12:57PM  Zogenix (ZGNX) Stock Soars on Anti-Seizure Drug Results InvestorPlace
11:51AM  Why Zogenix Inc. Is Soaring Today Motley Fool
10:10AM  Zogenix's seizure drug clears late-stage trial, shares soar Reuters
07:20AM  Zogenix shares soar 19% premarket after news of positive trial for severe epilepsy treatment MarketWatch
07:09AM  Zogenix's treatment for rare epilepsy meets advanced study goal Reuters
07:00AM  Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome GlobeNewswire
Jul-03-18 09:31AM  3 Biotech Stocks With Major Catalysts Incoming Motley Fool
Jul-02-18 04:32PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
08:00AM  Zogenix Welcomes New Global Chief Commercial Officer GlobeNewswire
Jun-27-18 12:25PM  Heres the Reason that GWPH Stock Tumbled Despite Regulatory Victory InvestorPlace
Jun-19-18 08:46AM  Are Options Traders Betting on a Big Move in Zogenix (ZGNX) Stock? Zacks
Jun-07-18 07:50AM  Free Daily Technical Summary Reports on Endo International and Three Other Healthcare Stocks ACCESSWIRE
Jun-01-18 04:24PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-20-18 01:11PM  This Cannabis-Based Drug Is On the Verge of Making History Motley Fool
May-15-18 09:41AM  Edited Transcript of ZGNX earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-14-18 08:21AM  Despite Losing $88 Million in Q2, This Pot Stock Still Has More Cash Than Any of Its Peers Motley Fool
08:00AM  Zogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference GlobeNewswire
May-09-18 04:47PM  Zogenix: 1Q Earnings Snapshot Associated Press
04:01PM  Zogenix Provides Corporate Update and Reports First Quarter Financial Results GlobeNewswire
May-04-18 08:21AM  A Major Marijuana Milestone Is Less Than 2 Months Away Motley Fool
08:00AM  Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9 GlobeNewswire
May-01-18 05:00PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Apr-27-18 08:00AM  Zogenix Announces Initial Quality of Life and Cognitive Function Data From Phase 3 Trial of ZX008 in Dravet Syndrome GlobeNewswire
Apr-25-18 08:00AM  Zogenix Announces Presentation of New Efficacy and Safety Data from its First Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome GlobeNewswire
08:00AM  Report: Exploring Fundamental Drivers Behind Urban Edge Properties, FLIR, Zogenix, Watts Water Technologies, CDW, and BMC Stock New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Apr-11-18 08:00AM  Zogenix to Participate in LEERINK Partners CNS Day GlobeNewswire
Apr-04-18 07:30AM  Here's Why The Mayo Clinic Owns 10% of This Unknown Epilepsy Stock with Big Upcoming FDA Catalyst ACCESSWIRE
Mar-28-18 07:20AM  Wired News Shire Collaborates with NanoMedSyn to Treat Potential Lysosomal Storage Disorder ACCESSWIRE
Mar-20-18 06:34AM  Why Didn't Investors Care About This Marijuana Stock's Big News? Motley Fool
Mar-09-18 09:31AM  Employee Stock Options Liability Significant For Zogenix Forbes
Mar-08-18 12:11AM  Edited Transcript of ZGNX earnings conference call or presentation 6-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-07-18 05:03AM  Zogenix reports 4Q loss Associated Press
Mar-06-18 04:01PM  Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
03:00PM  Why Zogenix Inc. Shares Shot Up 16.6% in February Motley Fool
12:30PM  Zogenix, Inc. to Host Earnings Call ACCESSWIRE
Mar-05-18 08:50AM  Why Earnings Season Could Be Great for Zogenix (ZGNX) Zacks
Mar-01-18 08:25AM  Report: Developing Opportunities within Inseego, Cato, FleetCor Technologies, Zogenix, Verisk Analytics, and XPO Logistics Future Expectations, Projections Moving into 2018 GlobeNewswire
Feb-27-18 08:00AM  Zogenix to Release Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call and Webcast on March 6 GlobeNewswire
Feb-23-18 11:52AM  Why Leerink Adjusted Upside Expectations For 3 Biotechs Benzinga
Feb-20-18 08:16PM  Zogenix Inc. (ZGNX) and Arena Pharmaceuticals, Inc. (ARNA) Helped This Healthcare-Focused Fund Earn Double-Digit Returns Insider Monkey
Feb-08-18 08:00AM  Zogenix to Participate in Leerink Partners 7th Annual Global Healthcare Conference GlobeNewswire
Feb-06-18 08:00AM  Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome GlobeNewswire +8.71%
Jan-31-18 04:05PM  Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome GlobeNewswire
Jan-21-18 07:07AM  This Marijuana Stock Just Might Have 1 of the Biggest New Drug Launches of 2018 Motley Fool
Jan-10-18 07:00AM  The Potential to Outmaneuver Marijuana Sent This Company's Stock Soaring 229.6% in 2017 Motley Fool
Jan-04-18 08:30AM  Analysis: Positioning to Benefit within FleetCor Technologies, Zogenix, BioTelemetry, Modine Manufacturing, Navigant Consulting, and CalAmp Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -6.40%
Dec-28-17 04:08PM  Stocks Close Mildly Higher; Bank, Biotech, Booze Company Break Out Investor's Business Daily
Dec-27-17 12:45PM  Ganaxalone Faces Stiff Competition from Other Drugs under Development Market Realist
Dec-20-17 07:22AM  Zogenix, Inc. is trading above its 50 day moving average : ZGNX-US : December 20, 2017 Capital Cube
Dec-06-17 12:25PM  Zogenix, Inc. Value Analysis (NASDAQ:ZGNX) : December 6, 2017 Capital Cube
06:31AM  5 Key Things to Know About This Leading Marijuana Stock's Future Motley Fool
Dec-05-17 07:48AM  Zogenix, Inc. breached its 50 day moving average in a Bearish Manner : ZGNX-US : December 5, 2017 Capital Cube
Dec-04-17 08:00AM  Zogenix Announces New Positive Efficacy and Safety Data from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome GlobeNewswire -11.25%
Nov-29-17 08:05AM  Zogenix Announces Initiation of Phase 3 Trial for ZX008 in Lennox-Gastaut Syndrome GlobeNewswire
08:00AM  Zogenix to Participate in the Global Mizuho Investor Conference 2017 GlobeNewswire
Nov-28-17 08:00AM  Zogenix To Host Call with Pediatric Epilepsy Expert Joseph Sullivan, M.D., on Dravet Syndrome and ZX008 on Monday, December 4 GlobeNewswire
Nov-27-17 01:23PM  As Zogenix Develops Its Seizure Treatment Pipeline, Analyst Predicts More Upside Benzinga
Nov-21-17 08:00AM  New Data from Zogenixs Phase 3 Trial of ZX008 in Dravet Syndrome (Study 1) and Findings on Disease Impact to be Presented at 71st American Epilepsy Society Annual Meeting GlobeNewswire
Nov-16-17 08:58AM  Implied Volatility Surging for Zogenix (ZGNX) Stock Options Zacks
Nov-14-17 08:00AM  Zogenix to Present at Stifel 2017 Healthcare Conference GlobeNewswire
Nov-10-17 12:24PM  Edited Transcript of ZGNX earnings conference call or presentation 7-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-07-17 05:02PM  Zogenix reports 3Q loss Associated Press
04:01PM  Zogenix Provides Corporate Update and Reports Third Quarter 2017 Financial Results GlobeNewswire
12:00PM  Zogenix, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-17 10:49AM  What's Behind GW Pharmaceuticals' 6.4% Gain in October? Motley Fool
10:41AM  GW Pharmaceuticals Just Delivered Some Good News About Its Marijuana-Based Drug Motley Fool
Oct-31-17 08:00AM  Zogenix to Release Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7 GlobeNewswire
07:32AM  Could Marijuana Stock GW Pharmaceuticals Soar More Than 50%? Motley Fool
Oct-27-17 11:24AM  ETFs with exposure to Zogenix, Inc. : October 27, 2017 Capital Cube
Oct-19-17 02:01AM  High Seizure Frequency in Children with Dravet Syndrome Negatively Impacts Quality of Life, New International Caregiver Survey Finds GlobeNewswire
Oct-16-17 10:01AM  ETFs with exposure to Zogenix, Inc. : October 16, 2017 Capital Cube
08:00AM  Interim Survey Results Demonstrate Impact on Siblings of Children Suffering from Severe Epilepsy GlobeNewswire
Oct-06-17 08:21AM  This Potential Billion-Dollar Marijuana-Based Drug Suddenly Finds Itself in Deep Trouble Motley Fool
Oct-05-17 04:35PM  Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
11:27AM  ETFs with exposure to Zogenix, Inc. : October 5, 2017 Capital Cube
Oct-04-17 09:06AM  Zogenix, Inc. :ZGNX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017 Capital Cube
08:00AM  Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Zogenix ACCESSWIRE
06:31AM  A Drug That May Be Better Than Marijuana Sent This Company's Stock Soaring 196% in September Motley Fool
Oct-03-17 08:50AM  Implied Volatility Surging for Zogenix (ZGNX) Stock Options Zacks
07:18AM  How Risky Is GW Pharmaceuticals Stock After Zogenix's Big News? Motley Fool
Oct-02-17 08:06PM  Zogenix Prices Public Offering of Common Stock GlobeNewswire +10.98%
04:16PM  Zogenix Stock Nears 7-Year High On Excitement Over Epilepsy Drug Investor's Business Daily
02:31PM  Zogenix Soars 10% Today Despite Diluting Investors Motley Fool
11:26AM  Zogenix, Inc. Value Analysis (NASDAQ:ZGNX) : October 2, 2017 Capital Cube
10:15AM  Company News For Oct 2, 2017 Zacks
08:20AM  Today's Research Reports on Stocks to Watch: GW Pharmaceuticals and Zogenix Inc. ACCESSWIRE
07:20AM  Featured Company News - Zogenix Shares Positive Results from Phase-3 Clinical Trial of ZX008 for Treating Dravet Syndrome ACCESSWIRE
06:53AM  Zogenix Announces Proposed Public Offering of 4,300,000 Shares of Common Stock GlobeNewswire
Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. Its lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farfel Gail MEVP/Chief Development OfficerJun 12Option Exercise13.965,00069,80012,261Jun 13 08:57 PM
Farfel Gail MEVP/Chief Development OfficerJun 12Sale45.005,118230,3107,143Jun 13 08:57 PM
GARNER CAM LDirectorMay 16Option Exercise28.002186,104218May 17 04:12 PM
GARNER CAM LDirectorMay 16Sale39.902188,6980May 17 04:12 PM
HAWLEY ROGERDirectorMar 13Option Exercise16.1927,760449,424118,335Mar 14 04:15 PM
HAWLEY ROGERDirectorMar 13Sale44.6527,7601,239,43790,575Mar 14 04:15 PM
BOCK LOUIS CDirectorMar 12Option Exercise15.7524,716389,40024,716Mar 14 04:15 PM
HAWLEY ROGERDirectorMar 12Option Exercise28.007,240202,72097,815Mar 14 04:15 PM
HAWLEY ROGERDirectorMar 12Sale44.977,240325,54990,575Mar 14 04:15 PM
BOCK LOUIS CDirectorMar 12Sale44.8324,7161,108,1340Mar 14 04:15 PM
Galer Bradley S.EVP/Chief Medical OfficerDec 13Buy36.591,34649,2454,033Dec 15 04:26 PM
HAWLEY ROGERDirectorDec 11Option Exercise14.0963,203890,440135,316Dec 11 08:13 PM
HAWLEY ROGERDirectorDec 11Sale36.8463,2032,328,44390,575Dec 11 08:13 PM
HAWLEY ROGERDirectorDec 08Option Exercise15.0411,797177,427102,372Dec 11 08:13 PM
HAWLEY ROGERDirectorDec 08Sale37.0211,797436,70490,575Dec 11 08:13 PM
HAWLEY ROGERDirectorDec 07Option Exercise11.5756,370652,217110,575Dec 11 08:13 PM
HAWLEY ROGERDirectorDec 07Sale36.5456,3702,059,61390,575Dec 11 08:13 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 03Buy37.50300,00011,250,0003,970,357Oct 03 02:52 PM
PERCEPTIVE ADVISORS LLC10% OwnerSep 29Buy32.83222,0557,290,0593,670,357Oct 03 08:45 AM